In brief, inflammasomes (eg., NLRP3 inflammasome) involve in the pathophysiology of fibrotic lung diseases, studies suggest that NLRP3 inhibition could provide a promising approach against the fibrotic pulmonary process. The gene discussed is NLRP3; the disease is lung disorder.